Abstract:Introduction: Several putative biomarkers of accelerated biological aging have been developed from patterns of DNA methylation in blood and other tissues (DNAm-Age scores). Some of these DNAm-Age scores have been found to be associated with age-related outcomes such as CVD and all-cause mortality, but their associations with frailty are unclear. We hypothesized that higher DNAm-Age scores measured in midlife are associated with higher odds of frailty and its components in late life. Methods: DNAm was measured at visit 2 or 3 in leukocyte DNA from 812 African American (AA) and 400 European American (EA) participants (mean age=54 years in AA, 57 years in EA), and was used to calculate three different DNAm-Age scores (Horvath, Hannum, and PhenoAge). Frailty status was assessed at visit 5, and dichotomized (frail/pre-frail or robust) using the following component criteria: slow walking speed, low grip strength, weight loss, low physical activity, and exhaustion. Logistic regression tested the associations of DNAm-Age scores, as the predictors of frailty status or each frailty component. Model 1 adjusted for visit 2 or 3 age, sex, education, white blood cell count, cell type proportions, and technical variables and model 2 additionally adjusted for BMI, smoking, alcohol, and visit 5 CHD, stroke, hypertension, and T2D. Inverse probability weights accounted for cohort attrition prior to frailty assessment. The Bonferroni-corrected threshold for statistical significance was set to p<8.3E-3 (0.05/6). Results: In African American participants, a 4-year increase in the PhenoAge score in midlife was associated with frailty in late life (OR=1.21, 95% CI=1.09, 1.35, p=3E-4) in model 1, which was attenuated in model 2 (OR=1.13, 95% CI=1.02, 1.26, p=2.4E-2), and with physical activity (model 2 OR=1.32, 95% CI=1.13-1.53, p=4E-4); a 4-year increase in the Hannum score was associated with the exhaustion and grip strength components (OR=1.33, 95% CI=1.13-1.57, p=6E-4; OR=1.38, 95% CI=1.16-1.64, p=3E-4, respectively). In European American participants, the DNAm-Age scores were not associated with frailty however a 4-year increase in both the Horvath and Hannum scores was associated with the weight loss component (model 2 OR=1.56, 95% CI=1.20-2.02, p=9E-4; OR=2.37, 95% CI=1.49-3.76, p=2E-4), respectively. Conclusions: In African American ARIC participants, a higher mid-life PhenoAge score was associated with higher odds of frailty/pre-frailty in late life, consistent with accelerated biological aging, but was not significant after further adjustment. The Horvath, Hannum, and PhenoAge scores were associated with some frailty components in African American and European American ARIC participants, consistent with accelerated biological aging. Following replication, future studies should examine the causal relationship between DNAm-Age, frailty, and frailty components.

Epigenome‐wide analysis of frailty: Results from two European twin cohorts

Epigenome-Wide Scans Identify Differentially Methylated Regions for Age and Age-Related Phenotypes in A Healthy Ageing Population

Tobacco Smoking and Smoking-Related DNA Methylation Are Associated with the Development of Frailty among Older Adults.

Abstract P271: Dna Methylation Measures of Aging in Midlife Are Associated with Frailty Components in African American and European American Older Adults: the Atherosclerosis Risk in Communities (ARIC) Study

Genome-wide association studies identify 137 loci for DNA methylation biomarkers of ageing

A genome‐wide association study of the frailty index highlights brain pathways in ageing

Unraveling the metabolic underpinnings of frailty using multicohort observational and Mendelian randomization analyses

Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging

Comparative validation of three DNA methylation algorithms of ageing and a frailty index in relation to mortality: results from the ESTHER cohort study

Large-scale genome-wide analyses with proteomics integration reveal novel loci and biological insights into frailty

DNA methylation in genes of longevity-regulating pathways: association with obesity and metabolic complications

A cross-tissue transcriptome-wide association study identifies new susceptibility genes for frailty

Epigenetic and Metabolomic Biomarkers for Biological Age: A Comparative Analysis of Mortality and Frailty Risk

Mortality Associations With DNA Methylation-Based Biological Aging and Physical Functioning Measures Across a 20-Year Follow-up Period

DNA methylation correlates of chronological age in diverse human tissue types

Epigenome-wide association study of leukocyte telomere length.

A Longitudinal Study of DNA Methylation As a Potential Mediator of Age-Related Diabetes Risk

Epigenome-wide association study identifies DNA methylation loci associated with handgrip strength in Chinese monozygotic twins

DNA methylation GrimAge strongly predicts lifespan and healthspan

The epigenetics of frailty

Dissecting the shared genetic architecture between Alzheimer's disease and frailty: a cross-trait meta-analyses of genome-wide association studies